SHARE-BASED COMPENSATION AND WARRANTS (Tables)
|
12 Months Ended |
Jun. 30, 2026 |
| SHARE-BASED COMPENSATION AND WARRANTS |
|
| Schedule of the number of shares authorized, outstanding, and available for future grants under stock option |
Presented below is a summary of the number of shares authorized, outstanding, and available for future grants under the Company’s equity incentive plans as of June 30, 2026: | | | | | | | | | Number of Shares | Description | | Authorized | | Outstanding | | Available | 2015 Plan | | 14,000 | | 14,000 | | — | 2016 Plan | | 115,200 | | 115,200 | | — | 2019 Plan | | 200,000 | | 200,000 | | — | 2021 Plan | | 20,193,552 | | 13,664,566 | | 6,528,986 | Inducement Awards | | 1,500,000 | | 705,000 | | 795,000 | Total | | 22,022,752 | | 14,698,766 | (1) | 7,323,986 |
| (1) | Consists of approximately 12.5 million shares outstanding under stock option agreements and 2.2 million shares under restricted stock units. |
|
| Schedule of the stock option plans |
The following table summarizes the combined stock option activity under the Company’s equity incentive plans and inducement awards, for the fiscal years ended June 30, 2026 and 2025: | | | | | | | | | | | | | | | | | 2026 | | 2025 | | | Shares | | Price (1) | | Term (2) | | Shares | | Price (1) | | Term (2) | Outstanding, beginning of fiscal year | | 13,027,994 | | $ | 4.03 | | 7.7 | | 10,890,540 | | $ | 3.82 | | 8.1 | Granted | | 2,506,000 | | | 8.64 | | | | 3,246,300 | | | 4.57 | | | Exercised | | (825,953) | (3) | | 2.18 | | | | (488,742) | (3) | | 2.85 | | | Expired | | (346,745) | | | 4.86 | | | | (69,666) | | | 12.17 | | | Forfeited | | (1,892,865) | | | 6.22 | | | | (550,438) | | | 3.08 | | | Outstanding, end of fiscal year | | 12,468,431 | (4) | | 4.73 | | 6.9 | | 13,027,994 | (4) | | 4.03 | | 7.7 | Vested, end of fiscal year | | 9,145,633 | (5) | | 4.37 | | 6.2 | | 7,127,835 | (5) | | 4.48 | | 6.9 |
| (1) | Represents the weighted average exercise price. |
| (2) | Represents the weighted average remaining contractual term until the stock options expire. |
| (3) | The total intrinsic value (the amount by which the fair market value exceeded the exercise price) of stock options exercised during the year ended June 30, 2026 and 2025, was $2.5 million and $0.9 million, respectively. |
| (4) | As of June 30, 2026 and 2025, the intrinsic value of outstanding stock options was approximately $19.4 million and $14.9 million, respectively. |
| (5) | As of June 30, 2026 and 2025, the aggregate intrinsic value of vested stock options was approximately $16.1 million and $8.5 million, respectively. |
|
| Schedule of the fair value of stock options |
The fair value of stock options was estimated on the dates of grant using the BSM option-pricing model, with the following weighted-average assumptions for the fiscal years ended June 30, 2026 and 2025: | | | | | | | | | | 2026 | | 2025 | Market price of common stock on grant date | | $ | 8.64 | | $ | 4.57 | | Expected volatility | | | 84 | % | | 84 | % | Risk free interest rate | | | 3.8 | % | | 4.2 | % | Expected term (years) | | | 5.9 | | | 5.9 | | Dividend yield | | | 0 | % | | 0 | % |
|
| Schedule of the combined RSU activity |
The following table summarizes the RSU activity under the Company’s 2021 Plan, for the fiscal years ended June 30, 2026 and 2025: | | | | | | | | | | | | | 2026 | | 2025 | | | Shares | | Price (1) | | Shares | | Price (1) | Unvested, beginning of fiscal year | | 1,056,500 | | $ | 4.55 | | — | | $ | — | Granted | | 1,915,000 | | | 10.11 | | 1,056,500 | | | 4.55 | Vested | | (360,165) | (2) | | 4.61 | | — | | | — | Forfeited | | (381,000) | | | 9.56 | | — | | | — | Unvested, end of fiscal year | | 2,230,335 | | | 8.46 | | 1,056,500 | | | 4.55 |
| (1) | Represents the weighted average fair value per share based on the closing market price of the Company’s common stock on the grant date of the respective RSUs. |
| (2) | Based on the closing market price of the Company’s common stock on the respective vesting dates, the aggregate fair value for the RSUs that vested during the fiscal year ended June 30, 2026, amount to $1.2 million or approximately $3.24 per share. |
|
| Schedule of share-based compensation expense |
Share-based compensation expense is included under the following captions in the consolidated statements of operations for the fiscal years ended June 30, 2026 and 2025 (in thousands): | | | | | | | | | 2026 | | 2025 | Research and development | | $ | 6,473 | | $ | 3,502 | General and administrative | | | 7,987 | | | 3,619 | Total | | $ | 14,460 | | $ | 7,121 |
|
| Legacy warrants |
|
| SHARE-BASED COMPENSATION AND WARRANTS |
|
| Schedule of warrant activity |
The following table summarizes the activity related to the Legacy Warrants for the fiscal years ended June 30, 2026 and 2025: | | | | | | | | | | | | | | | | | 2026 | | 2025 | | | Shares | | Price (1) | | Term (2) | | Shares | | Price (1) | | Term (2) | Outstanding, beginning of fiscal year | | 850,442 | | $ | 19.90 | | 2.3 | | 860,562 | | $ | 20.28 | | 3.2 | Expirations | | (660) | | | 67.55 | | | | (10,120) | | | 52.20 | | | Outstanding, end of fiscal year | | 849,782 | | | 19.86 | | 1.3 | | 850,442 | | | 19.90 | | 2.3 |
| (1) | Represents the weighted average exercise price. |
| (2) | Represents the weighted average remaining contractual term for the number of years until the warrants expire. |
|